Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo

American Journal of Pathology

Volumn 152, Issue 2, 1998, Pages 353-358

  Giachelli, Cecilia M ^a   Lombardi, Donna ^a   Johnson, Richard J ^a   Murry, Charles E ^a   Almeida, Manuela ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARTIC ACID; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GLYCINE; NEUTRALIZING ANTIBODY; OSTEOPONTIN; RECOMBINANT PROTEIN;

ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODIES; CELL ADHESION; CELL MOVEMENT; INJECTIONS, INTRADERMAL; MACROPHAGES; MALE; MICE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; OSTEOPONTIN; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SIALOGLYCOPROTEINS; SKIN;

EID: 0031906847     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Giachelli CM, Schwartz SM, Liaw L: Molecular and cellular biology of osteopontin: potential role in cardiovascular disease. Trends Cardiovasc Med 1995, 5:88-95
2. Giachelli CM, Pichler R, Lombardi D, Denhardt DT, Alpers CE, Schwartz SM, Johnson RJ: Osteopontin expression in angiotensin II induced tubulointerstitial nephritis. Kidney Int 1994, 45:515-524
3. Pichler R, Giachelli CM, Lombardi D, Pippin J, Gordon K, Alpers CE, Schwartz SM, Johnson RJ: Tubulointerstitial disease in glomerulonephritis: potential role of osteopontin (uropontin). Am J Pathol 1994, 144:915-926
4. Diamond JR, Kees-Folt K, Ricardo SD, Pruznak A, Eufemio: Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis. Am J Pathol 1995, 146:1455-1466
5. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM: Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 1993, 92:1686-1696
6. O'Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, Giachelli CM: Osteopontin is synthesized by macrophages, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Atheroscler Thromb 1994, 14:1648-1656
7. Hirota S, Imakita M, Hohri K, Ito A, Morii E, Adachi S, Kim H-M, Kitamura Y, Yutani C, Nomura S: Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques: a possible association with calcification. Am J Pathol 1993, 143:1003-1008
8. Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K: Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest 1993, 92:2814-2820
9. Murry CE, Giachelli CM, Schwartz SM, Vracko R: Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 1994, 145:1450-1462
10. O'Brien KD, Kuusisto J, Reichenbach DD, Ferguson M, Giachelli CM, Alpers CE, Otto CM: Osteopontin is expressed in human aortic valvular lesions: evidence that aortic valve calcification may be actively regulated. Circulation 1995, 92:2163-2168
11. Srivatsa SS, Harrity PJ, Maercklein PB, Kleppe L, Veinot J, Edwards WD, Johnson CM, Fitzpatrick LA: Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic valves. J Clin Invest 1997, 99:996-1009
12. Mohler ER, Adam LP, McClelland P, Graham L, Hathaway DR: Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 1997, 17:547-552
13. Brown LF, Papadopoulos SA, Berse B, Manseau EJ, Tagnazzi K, Perruzzi CA, Dvorak HF, Senger DR: Osteopontin expression and distribution in human carcinomas. Am J Pathol 1994, 145:610-623
14. Liaw L, Linder V, Schwartz SM, Chambers AF, Giachelli CM: Osteopontin and β3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate arg-gly-asp-dependent endothelial migration in vitro. Circ Res 1995, 77:665-672
15. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM: Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 1994, 74:214-224
16. Liaw L, Lombardi DM, Almeida MM, Schwartz, deBlois D, Giachelli CM: Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening following endothelial denudation. Arterioscler Thromb Vase Biol 1997, 17:188-193
17. Riches DWH: Macrophage involvement in wound repair, remodeling, and fibrosis. The Molecular and Cellular Biology of Wound Repair. Edited by Clark RAF. New York, Plenum, 1988, pp 95-141
18. Wang X, Louden C, Ohlstein EH, Stadel JM, Gu J, Tue TL: Osteopontin expression in platelet derived growth factor-stimulated smooth muscle cells and carotid artery after balloon angioplasty. Arterioscler Thromb Vasc Biol 1996, 16:1365-1372
19. Patarca R, Saavedra RA, Cantor H: Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1 gene. Crit Rev Immunol 1993, 13:225-246
20. Ashizawa N, Graf K, Do YS, Nunohiro T, Giachelli CM, Meehan WP, Tuan TL, Hsueh WA: Osteopontin is produced by rat cardiac fibroblasts and mediates All-induced DNA synthesis and collagen gel contraction. J Clin Invest 1996, 98:2218-2227
21. Hwang S, Lopez CA, Heck DE, Garder CR, Laskin DL, Laskin JD, Denhardt DT: Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem 1995, 269:711-715
22. Hunter GK, Kyle CL, Goldberg HA: Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. Biochem J 1994, 300: 723-726
23. Ross FP, Chappel J, Alvarez JI, Sander D, Butler WT, Farach-Carson MC, Mintz DA, Robey PG, Teitelbaum SL, Cheresh DA: Interactions between bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin αvβ3 potentiate bone resorption. J Biol Chem 1993, 268:9901-9907
24. Miyazaki Y, Setoguchi M, Yoshida S, Higuchi Y, Akizuki S, Yamamoto S: The mouse osteopontin gene: expression in monocytic lineages and complete nucleotide sequence. J Biol Chem 1990, 265:14432-14438
25. McKee MD, Nanci A: Secretion of osteopontin by macrophages and its accumulation at tissue surfaces during wound healing in mineralized tissues: a potential requirement for macrophage adhesion and phagocytosis. Anat Rec 1996, 245:394-409
26. Chambers AF, Wilson SM, Kerkvliet N, O'Malley FP, Harris JF, Casson AG: Osteopontin expression in lung cancer. Lung Cancer 1996, 15:311-323
27. Krause SW, Rehli M, Kreutz M, Schwarzfischer L, Paulauskis JD, Andreesen R: Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukocyte Biol 1996, 60:540-545
28. Graves MG, Rosenstreich DL, Taylor BA, Osterman JV: Host defenses in experimental scrub typhus: mapping the gene that controls natural resistance in mice. J Immunol 1980, 125:1395-1399
29. Fet V, Dickinson ME, Hogan BLM: Localization of the mouse gene for secreted phosphoprotein 1 (spp-1) (2aR, osteopontin, bone sialoprotein 1, 44 kd bone phosphoprotein, tumor secreted phosphoprotein) to chromosome 5, closely linked to Ric (Rickettsia resistance). Genomics 1989, 5:375-377
30. Nasu K, Ishida T, Setoguchi M, Higuchi Y, Akizuki S, Yamamoto S: Expression of wild-type and mutated rabbit osteopontin in Escherichia coli and their effects on adhesion and migration of P388D1 cells. Biochem J 1995, 307:257-265
31. Singh RP, Patarca R, Schwartz J, Singh P, Cantor H: Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J Exp Med 1990, 171:1931-1942
32. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM: The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins: role of αvβ3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest 1995, 95:713-724
33. Yue TL, McKenna J, Ohlstein EH, Farach-Carson MC, Butler WT, Johanson K, McDevitt P, Feuerstein GZ, Stadel JM: Osteopontin-stimulated vascular smooth muscle cell migration is mediated by β3 integrin. Exp Cell Res 1995, 214:459-464
34. Smith LL, Ling LE, Cheung HK, Chen, Sheppard DS, Pytela R, Giachelli CM: Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by α9β1 integrin. J Biol Chem 1996, 271:28485-28491
35. Bautista DS, Saad Z, Chambers AF, Tonkin KS, O'Malley FP, Singhal H, Tokmakejian S, Bramwell V, Harris JF: Quantification of osteopontin in human plasma with an ELISA: basal levels in pre-and post-menopausal women. Clin Biochem 1996, 29:231-239
36. Weber GF, Ashkar S, Glimcher ML, Cantor H: Receptor-ligand interaction between CD44 and osteopontin (eta-1). Science 1996, 271: 509-512